Bone Tumors
Eosinophilic Granuloma
James C. Wittig, MD Sarcoma Surgeon Orthopedic Oncologist
GENERAL INFORMATION
This is a benign proliferation of Langerhans cells usually accompanied with eosinophils, lymphocytes, neutrophils and scattered plasma cells. There may be solitary or multiple lesions confined to bone 70% of cases consist of a solitary lesion Seldom leads to disseminated systemic disease Viewed as disorder of immune regulation or reactive process rather than neoplasm All organ systems may be affected with disseminated forms
Hand-Schuller-Christian Disease (1-5 years): chronic disseminated histiocytosis Letterer-Siwe disease (<1 year): acute or subacute disseminated histiocytosis Uniformly fatal Solitary EG is twice as common as multifocal EG May arise from any bone and any site within a bone (epiphyseal, metaphyseal, diaphyseal) Radiographically variable appearance: may appear benign (geographic) or malignant (permeative or moth eaten)
Hand-Schuller-Christian Disease
Triad: Destructive skeletal lesions Exophthalmos Diabetes Insipidus 10% of patients with unifocal EG develop multifocal and extraskeletal disease Usually <5 years old Hepatosplenomegaly, adenopathy, anemia, fever, neurological complaints Fatal in 15% Any bone but 90% have skull involvement
Letterer-Siwe Disease
Develops in 1st year of life Disseminated disease and small bone lesions Fatal in 95% who develop before 1 year of life
CLINICAL PRESENTATION
Signs/Symptoms: Pain and soft tissue swelling Temporal bone disease is clinically indistinguishable from otitis media or mastoiditis May have a fever Mild peripheral eosinophilia (5%-10% of patients) Prevalence: Male predilection (2:1)
Age: 1 month – 71 years Most common age 5-15 years old 85% within first 3 decades 60% within first decade
Sites: Flat Bones (most common—70%) Skull Pelvis Femur Humerus Hands and Feet are rare in solitary disease
RADIOGRAPHIC PRESENTATION
Radiology: Permeative with periosteal reaction (lamellated) Geographic Rind of sclerosis Soft tissue mass (5-10%) Sequestrum (button-like); Hole in a Hole
|
 |
|
Skull: beveled edge; button sequestrum Flat bone: hole in a hole Spine: vertebra plana Long bone: Diaphysis: (58%) Metadiaphysis (18%) Metaphysis (28%) Epiphysis (2%)
|
 |
 X-Ray: Eosinophilic Granuloma of Skull
|

Geographic Lesion with Periosteal Reaction |

Geographic Lytic Lesion Periosteal Reaction | X-ray: Eosinophilic Granuloma of Femur
 |
Geographic Lesion
Lamellated Periosteal Reaction
|
 | X-ray: Eosinophilic Granuloma of Femur
|
Permeative Lesion of Diaphysis Periosteal Reaction
Bone Scan is Variable Uptake Intense, Mild or Cold |
 | X-ray/Bone Scan: Eosinophilic Granuloma of Femur
MRI: Eosinophilic Granuloma Marrow replacement on T1 High SI on T2 ST mass possible
Langerhans Cell Histiocytosis
 |
Geographic Lesion with Sclerotic Rim
|
 | X-ray: Eosinophilic Granuloma of Femur
X-ray: Eosinophilic Granuloma of Clavicle Permeative Lesion

Plain X-ray: Eosinophilic Granuloma of Humerus Permeative Lesion

MRI T2: Eosinophilic Granuloma of Scapula Spine

X-ray: Eosinophilic Granuloma of Spine Vertebra Plana
GROSS PATHOLOGY
Gross appearance not distinctive Depending on mixture of cells, may be yellow, gray, or brown Older lesions are yellow due to regression and accumulation of lipid in histiocytes and Langerhans cells Intralesional hemorrhage exists
MICROSCOPIC PATHOLOGY
Langerhans cell is diagnostic and clonal proliferation Nuclei show prominent nuclear groove (coffee-bean) Also composed of eosinophils and other inflammatory cells (non diagnostic component) Ratio of inflammatory cells to Langerhans cells varies Mitotic activity low Eosinophils dominate some areas forming diffuse sheets, excluding Langerhans cells Birbeck Granules: Electron Microscopy demonstrates granules that often take the form of a tennis raquet and form from complex invaginations of the cell membrane Vimentin, CD1 and S-100 positivity

Microscopic Pathology: Eosinophilic Granuloma Cells and No Matrix
|
Eosinophils
|
 | Microscopic Pathology: Eosinophilic Granuloma
|
Eosinophils
Langerhans Cells Coffee Bean Indented Nucleus |
 |
Microscopic Pathology: Eosinophilic Granuloma
 Microscopic Pathology: Eosinophilic Granuloma Low Power Langerhans Cells Mixed with Eosinophils

Microscopic Pathology: Eosinophilic Granuloma Intermediate Power Langerhans Cells Mixed with Eosinophils

Microscopic Pathology: Eosinophilic Granuloma High power Coffee Bean/Indented Nuclei of Langerhans Cells

Microscopic Pathology: Eosinophilic Granuloma Touch Prep of Langerhans Cells with Bean Shaped Nuclei
 Eosinophilic Granuloma: Vimentin Stain
 Eosinophilic Granuloma: CD1a Stain

Eosinophilic Granuloma: S-100 Stain
 Eosinophilic Granuloma: CD-10 Stain
 Eosinophilic Granuloma: Birbeck Granules
Birbeck Granules
DIFFERENTIAL DIAGNOSIS
Osteomyelitis Granulomatous Inflammation Tuberculosis Fungus Hodgkin Disease
BIOLOGICAL BEHAVIOR
Typically acts as a benign disorder Individual lesions may undergo partial or complete spontaneous resolution Patients with solitary lesions are at risk for developing additional bony lesions within6 months to 2 years Adult patients with more than 3 bone lesions are at risk for visceral involvement although death due to EG in adults is rare Children with multiple bone lesions are at risk for visceral involvement that may cause death. Children less than 2 who develop disseminated disease are at highest risk for death
TREATMENT
Majority of patients are cured by curettage or intralesional injection of a steroid Curettage and bone grafting for long bones and weight bearing bones at risk for fracture Intralesional steroids for non weightbearing bones Complete healing may take a year Low dose radiation may be valuable for inaccessible lesions Vertebral plana is braced and observed
PROGNOSIS
Complete healing after surgery may take 1 year Patients with intraosseous EG are at risk for developing additional lesions Pateints who develop additional bony lesions are at risk for organ involvement. Death is rare of adults, regardless of extend of lesions although children, especially when less than 2 years of age, more readily die from disseminated disease
|